Novartis hopes to commercialise "smart lens" within 5 years
ZURICH (Reuters) - Novartis (NOVN.VX) expects the "smart lens" technology it has licensed from Google (GOOGL.O) will take several years to develop, but hopes to have a product ready for market in about five years, the drugmaker's chief executive said on Tuesday.
"This isn't going to happen overnight because it's a breakthrough technology. It's not months, we're probably talking about years. We would hope to be able to commercialise within about five years," Joe Jimenez told Reuters in an interview.
Novartis said earlier on Tuesday it had struck an agreement with Google (GOOGL.O) to develop "smart lens" technology for medical use in the eye.
(Reporting by Caroline Copley and Paul Arnold.)
- Tweet this
- Share this
- Digg this
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- Japan, India vow to boost strategic ties during summit
- Federer marches on as wild weather, upsets hit U.S. Open
- Government urges court to leave some coal blocks with companies
- Dozens arrested at Made in America music festival in Los Angeles
A Chinese anti-trust regulator said on Monday it has given Microsoft Corp 20 days to reply to queries on the compatability of its Windows operating system and Office software suite amid a probe into the world's largest software company. Full Article
Data scientists are increasingly becoming important to the world's tech companies. Video